Prepare to be amazed by the knowledge and expertise of Prof. dr. John Kastelein, Emeritus professor of Medicine, previous chair of the Department of Vascular Medicine, AMC, University of Amsterdam.
John Kastelein is emeritus professor of Medicine, co-founder of UniQure and Xenon, both Nasdaq listed Biotech companies and currently is founder and Chief Science Officer (CSO) of NewAmsterdam Pharma, which received a Nasdaq listing in January of 2023. Valorisation of scientific ideas into Biotech companies is the specialty and the lifetime work of prof Kastelein, which makes his lecture a go-to event!